Managing AML in Older Adults Older adults represent a growing focus within the Acute Myeloid Leukemia Treatment Market because AML diagnosis becomes more common with age. Traditional intensive chemotherapy may not always be suitable for elderly patients due to existing health conditions. Physicians carefully evaluate heart, kidney, and liver function before choosing therapy. Lower-intensity treatments have expanded options for individuals unable to tolerate aggressive regimens. Oral medications and targeted therapies allow outpatient management in many cases. Ref - https://www.marketresearchfuture.com/reports/acute-myeloid-leukemia-treatment-market-3223